Skip to main content
. 2019 Nov 4;5(3):155–161. doi: 10.15420/cfr.2019.01.R1

Table 2: Indications for IV Vasoactive Drugs in Clinical Scenarios in Heart Failure.

Clinical Setting Agent
Increased pulmonary artery pressure
  • Levosimendan

  • Milrinone

Need for beta-blocker
  • Levosimendan

  • Milrinone

Hypotension
  • Dobutamine

  • Norepinephrine

  • Dopamine

Worsening renal function
  • Levosimendan

  • Dobutamine

  • Dopamine

Ischaemic disease
  • Levosimendan

  • Dobutamine